News Alert: Pfizer, BioNTech to seek authorization of second coronavirus booster shot for people 65 and older

The submission to the Food and Drug Administration from the companies, expected as soon as Tuesday, represents an effort to bolster waning immunity that occurs several months after the first booster, according to three people familiar with the situation. The application comes as administration officials and public health experts debate whether and when additional booster shots will be needed for most Americans. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Sign up for alerts News Alert March 15, 12:18 p.m. EDT Pfizer, BioNTech to seek authorization of second coronavirus booster shot for people 65 and older The submission to the Food and Drug Administration from the companies, expected as soon as Tuesday, represents an effort to bolster waning immunity that occurs several months after the first booster, according to three people familiar with the situation. The application comes as administration officials and public health experts debate whether and when additional booster shots will be needed for most Americans. Read more   Advertisement

Manage my email newsletters and alerts | Unsubscribe | Privacy Policy | Help You received this email because you signed up for news alerts or because it is included in your subscription. ©2022 The Washington Post | 1301 K St NW, Washington DC 20071